Insmed jumps over 18% on report Sanofi is weighing an acquisition
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Insmed shares surged more than 18% and were temporarily halted by a volatility circuit breaker after Bloomberg reported that Sanofi is considering an acquisition of the U.S. drugmaker. Our AI stock portfolio is beating the S&P 500 by 118%. Discover the stocks…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA possible large biopharma deal, not confirmed, can move the target stock and the potential buyer.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Insmed shares surged over 18% after Bloomberg reported Sanofi is weighing an acquisition.
- 02Sanofi is speaking with advisers as it evaluates a potential transaction.
- 03Discussions remain ongoing and any deal could still be weeks away.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets